Provided by Tiger Fintech (Singapore) Pte. Ltd.

Marinus Pharmaceuticals

0.5500
+0.0000
Volume:- -
Turnover:605.61K
Market Cap:30.35M
PE:-0.22
High:0.5500
Open:0.5500
Low:0.5500
Close:0.5500
Loading ...
Feb 11, 2025

Major Issues Report

Form 8-K - Current report
Feb 11, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 11, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 11, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 11, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 11, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 11, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 11, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 11, 2025

Employee Stock Ownership

Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments
Feb 11, 2025

Delisting

Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities
Dec 30, 2024

Major Issues Report

Form 8-K - Current report
Dec 30, 2024

Major Issues Report

Form 8-K - Current report
Dec 23, 2024

Major Issues Report

Form 8-K - Current report
Dec 11, 2024

Major Issues Report

Form 8-K - Current report
Dec 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 15, 2024

Major Issues Report

Form 8-K - Current report